OpenEvidence left Europe. What should clinicians look for now?
OpenEvidence became unavailable in the EU and UK in April 2026. Here is what European clinicians should demand from any evidence-search replacement.
Writing from the CliniAtlas team in Split on clinical evidence, regulation, and the search tools European medicine deserves. Articles are currently published in English.
OpenEvidence became unavailable in the EU and UK in April 2026. Here is what European clinicians should demand from any evidence-search replacement.
A guideline, regulatory assessment, randomized trial, and preprint answer different questions. CliniAtlas labels that context instead of flattening every reference into the same footnote.
Medical AI regulation starts with intended purpose and actual functionality. Here is how CliniAtlas defines its current evidence-review scope.
The Summary of Product Characteristics is the approved basis of information for European healthcare professionals. It should be easy to find beside the research literature.